These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31907628)

  • 1. Surfaces Affect Screening Reliability in Formulation Development of Biologics.
    Zidar M; Posnjak G; Muševič I; Ravnik M; Kuzman D
    Pharm Res; 2020 Jan; 37(2):27. PubMed ID: 31907628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic Investigation on Grinding-Induced Subvisible Particle Formation during Mixing and Filling of Monoclonal Antibody Formulations.
    Gikanga B; Hui A; Maa YF
    PDA J Pharm Sci Technol; 2018; 72(2):117-133. PubMed ID: 29030532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Introducing the Alba
    Chillon A; Pace A; Zuccato D
    PDA J Pharm Sci Technol; 2018; 72(4):382-392. PubMed ID: 29853611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The missing piece in the puzzle: Prediction of aggregation via the protein-protein interaction parameter A
    Koepf E; Schroeder R; Brezesinski G; Friess W
    Eur J Pharm Biopharm; 2018 Jul; 128():200-209. PubMed ID: 29723667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ReFOLD assay for protein formulation studies and prediction of protein aggregation during long-term storage.
    Svilenov H; Winter G
    Eur J Pharm Biopharm; 2019 Apr; 137():131-139. PubMed ID: 30818009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Container Closure System Integrity for Storage of Frozen Drug Products: Impact of Capping Force and Transportation.
    Nieto A; Roehl H; Adler M; Mohl S
    PDA J Pharm Sci Technol; 2018; 72(6):544-552. PubMed ID: 29853608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting the Agitation-Induced Aggregation of Monoclonal Antibodies Using Surface Tensiometry.
    Shieh IC; Patel AR
    Mol Pharm; 2015 Sep; 12(9):3184-93. PubMed ID: 26198590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Streamlined Bioanalytical Approach to Select a Compatible Primary Container System Early in Drug Development: A Toolbox for the Biopharmaceutical Industry.
    Singh R; Waxman L
    J Pharm Sci; 2020 Jan; 109(1):206-210. PubMed ID: 31545968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface-Induced Protein Aggregation and Particle Formation in Biologics: Current Understanding of Mechanisms, Detection and Mitigation Strategies.
    Kopp MRG; Grigolato F; Zürcher D; Das TK; Chou D; Wuchner K; Arosio P
    J Pharm Sci; 2023 Feb; 112(2):377-385. PubMed ID: 36223809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability Studies of a Freeze-Dried Recombinant Human Epidermal Growth Factor Formulation for Wound Healing.
    Santana H; García G; Vega M; Beldarraín A; Páez R
    PDA J Pharm Sci Technol; 2015; 69(3):399-416. PubMed ID: 26048746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Nanoparticle-Based Assay To Evaluate Surface-Induced Antibody Instability.
    Kopp MRG; Capasso Palmiero U; Arosio P
    Mol Pharm; 2020 Mar; 17(3):909-918. PubMed ID: 31917582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-linked silicone coating: a novel prefilled syringe technology that reduces subvisible particles and maintains compatibility with biologics.
    Depaz RA; Chevolleau T; Jouffray S; Narwal R; Dimitrova MN
    J Pharm Sci; 2014 May; 103(5):1384-93. PubMed ID: 24643773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting accelerated aggregation rates for monoclonal antibody formulations, and challenges for low-temperature predictions.
    Brummitt RK; Nesta DP; Roberts CJ
    J Pharm Sci; 2011 Oct; 100(10):4234-43. PubMed ID: 21671226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No Touching! Abrasion of Adsorbed Protein Is the Root Cause of Subvisible Particle Formation During Stirring.
    Sediq AS; van Duijvenvoorde RB; Jiskoot W; Nejadnik MR
    J Pharm Sci; 2016 Feb; 105(2):519-529. PubMed ID: 26869415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating factors leading to fogging of glass vials in lyophilized drug products.
    Abdul-Fattah AM; Oeschger R; Roehl H; Bauer Dauphin I; Worgull M; Kallmeyer G; Mahler HC
    Eur J Pharm Biopharm; 2013 Oct; 85(2):314-26. PubMed ID: 23791681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Small-scale Model to Assess the Risk of Leachables from Single-use Bioprocess Containers through Protein Quality Characterization.
    Xiao NJ; Medley CD; Shieh IC; Downing G; Pizarro S; Liu J; Patel AR
    PDA J Pharm Sci Technol; 2016 11/12; 70(6):533-546. PubMed ID: 27325598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linking aggregation and interfacial properties in monoclonal antibody-surfactant formulations.
    Kannan A; Shieh IC; Fuller GG
    J Colloid Interface Sci; 2019 Aug; 550():128-138. PubMed ID: 31055138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the Role of the Air-Solution Interface on the Mechanism of Subvisible Particle Formation Caused by Mechanical Agitation for an IgG1 mAb.
    Ghazvini S; Kalonia C; Volkin DB; Dhar P
    J Pharm Sci; 2016 May; 105(5):1643-1656. PubMed ID: 27025981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of Stress-Induced Aggregate Size Distributions and Morphological Changes of a Bi-Specific Antibody Using Orthogonal Techniques.
    Hamrang Z; Hussain M; Tingey K; Tracka M; Casas-Finet JR; Uddin S; van der Walle CF; Pluen A
    J Pharm Sci; 2015 Aug; 104(8):2473-81. PubMed ID: 26053418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shipping-Induced Aggregation in Therapeutic Antibodies: Utilization of a Scale-Down Model to Assess Degradation in Monoclonal Antibodies.
    Fleischman ML; Chung J; Paul EP; Lewus RA
    J Pharm Sci; 2017 Apr; 106(4):994-1000. PubMed ID: 27964939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.